This is a community-generated profile. If you would like to claim it, please .
DecImmune Therapeutics Funding
$0
22 rounds
DecImmune Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on February 26, 2013.
Funding Rounds
U
$2250000UnknownFeb 2013
U
$3200000UnknownSep 2010
Investors of DecImmune Therapeutics
Broadview Ventures
Rounds
U
HealthCare Ventures
Rounds
U
U
Astellas Venture Management
Rounds
U
U
Amgen
Rounds
U